Praveen Nekkar's lab determines that depression medications can help treat Alzheimer’s disease

Monday, October 22, 2018

There are over half a million Canadians living with dementia. Treatment of this devastating disorder is challenging as there are no drugs available to cure it. Developing a new drug, running clinical trials, and acquiring approval from regulatory agencies is expensive and time-consuming: the process can take decades and cost upwards of 4 billion dollars.

To avoid these barriers, Praveen Nekkar, a professor at the School of Pharmacy at Waterloo, is exploring drug repurposing – the practice of determining new therapeutic uses for drugs that are already approved by regulatory agencies. Nekkar and his group examined a class of drugs called selective serotonin uptake inhibitors (SSRIs). These drugs are typically used in conditions like depression. Nekkar’s team found that they can also play a role in preventing the progression of Alzheimer’s.

[Full Article: Science News]

  1. 2018 (52)
    1. December (2)
    2. November (4)
    3. October (2)
    4. September (4)
    5. August (4)
    6. July (7)
    7. June (7)
    8. May (6)
    9. April (5)
    10. March (3)
    11. February (6)
    12. January (2)
  2. 2017 (45)
    1. December (4)
    2. November (2)
    3. October (6)
    4. September (2)
    5. August (7)
    6. July (2)
    7. June (5)
    8. May (7)
    9. April (1)
    10. March (3)
    11. February (2)
    12. January (4)
  3. 2016 (25)
    1. December (1)
    2. November (2)
    3. October (1)
    4. September (4)
    5. August (2)
    6. July (1)
    7. June (3)
    8. May (3)
    9. April (1)
    10. March (5)
    11. January (2)
  4. 2015 (26)
  5. 2014 (6)
  6. 2013 (13)
  7. 2012 (6)